stopOverflowHandler
MONOCLONAL ANTIBODY TARGETING AURORA-A KINASE
Principal Investigator: C. PRIGENT
TECHNICAL DESCRIPTION

The present invention is a monoclonal antibody which targets the mammal aurora-A kinase (human and mouse). As the overexpression of aurora-A kinase has been observed in many tumors, it is very important to assess its expression.

Mice were injected with human recombinant aurora-A kinase et then killed. Spleen cells were extracted and fused with immortalized hamster cells to obtain a hybridoma. After many screening's a hybridoma was isolated that produces an antibody with a high affinity for the aurora-A kinase.



¡Para continuar la lectura conéctese ! au lieu de ¡Para leer la consecuencia, conectarse!
 
< Anterior   Siguiente >
 
 

indentificación






Direct Access
+33 1 40 51 00 90
BIO International Convention 2012

Rencontrez-nous du 18 au 21 juin 2012 à la Convention d’Affaires Internationale « BIO International ...
Details ...



Biovaria 2012, Munich, Germany 15th May 2012

The marketplace for life-science technologies from leading European research institutions and ...
Details ...



 
   
viagra 100mg